Experts in treating older cancer patients say it's important to think of each patient individually, not to assume that because someone has reached a certain age that he or she isn't going to be able to withstand surgeries, radiation or chemotherapy.
Experts in treating older cancer patients say it’s important to think of each patient individually, not to assume that because someone has reached a certain age that he or she isn’t going to be able to withstand surgeries, radiation or chemotherapy.
On the other hand, a person’s frailty and other medical conditions must be part of the conversation when discussing the repercussions of those treatments, which often cause life-altering side effects.
Many oncologists (particularly those focused on geriatrics) are giving these issues heightened consideration and are spending more time with patients and families figuring out what’s best and not just what makes sense on paper.
Read the full story here: http://bit.ly/1iDhEoz
Source: The Columbus Dispatch
NCCN Launches Pilot Project Aiming to Measure, Implement Health Equity in Cancer Care Practices
February 4th 2023Five leading academic cancer centers are assessing the feasibility of implementing the Health Equity Report Card pilot project as a tool that can both meaningfully and feasibly measure and report on equitable care practices.
Read More
Lymphoma Research Foundation CEO on Biden’s Cancer Moonshot, Financial Toxicity
February 3rd 2022On this episode of Managed Care Cast, we speak with Meghan Gutierrez, CEO of the Lymphoma Research Foundation, about financial toxicity, how the pandemic has affected patients’ financial needs when they have cancer, health care disparities and care gaps, and more.
Listen
Study Suggests MRI Is the Best Breast Cancer Screening Modality for Dense Breasts
February 1st 2023A review and meta-analysis published in the journal Radiology found MRI to be the most effective supplemental breast cancer screening method for women with dense breasts and negative mammogram results.
Read More
Interstitial Lung Abnormalities Impact OS in NSCLC Patients Receiving CRT, Adjuvant Durvalumab
January 19th 2023Pretreatment interstitial lung abnormalities were associated with worse overall and cause-specific survival in Japanese patients receiving chemoradiotherapy followed by adjuvant durvalumab for locally advanced non–small-cell lung cancer.
Read More
2 Clarke Drive
Cranbury, NJ 08512